MRD Monitoring in Acute Lymphoblastic Leukemia
0 意见
administrator
06/15/23
In this segment, Raoul Tibes, MD, PhD, discusses risk stratification based on minimal residual disease monitoring in patients with acute lymphoblastic leukemia achieve remission.
显示更多
脸书评论
没有找到评论